ToolGen, mCureX team up for mRNA-based gene therapy for rare eye disorders

2022.06.14 13:49:52

[Source: ToolGen]이미지 확대

[Source: ToolGen]

ToolGen has forged a partnership with mCureX for joint research and development of an mRNA-based gene therapy for rare eye disorders. The two companies will leverage the combination of ToolGen’s gene-editing solution and mCureX’s mRNA technology to develop a treatment for rare hereditary eye diseases.

[ⓒ Pulse by Maeil Business Newspaper & mk.co.kr, All rights reserved]

MOST READ MOST RECENT
  1. 1Korean gov’t launches startup fund to boost venture ecosystem
  2. 2“Grandpa Core” emerges as key fashion trend in Korea
  3. 3Korea’s secondary battery stocks slide amid sluggish EV demand
  4. 4Samsung Electronics begins mass producing 9th-gen V-NAND
  5. 5Housing prices to slow down from 2039 amid ultra-low birth rates: Stud..
  1. 1Korea to build industrial complex for SMR research in Gyeongju
  2. 2Samsung SDS CEO to give keynote speech at DTW 2024
  3. 3Korean gov’t launches startup fund to boost venture ecosystem
  4. 4Cuckoo to supply products to luxury hotels
  5. 5Chinese e-commerce giants expand presence in Korea
  6. 6Netmarble to release new MMORPG in 4 regions